Mostrar el registro sencillo del ítem
dc.contributor.author | Montes Delgado, Martin | |
dc.contributor.author | Sanchez, C. | |
dc.contributor.author | Lewis, D.E. | |
dc.contributor.author | Graviss, E.A. | |
dc.contributor.author | Seas Ramos, Carlos Rafael | |
dc.contributor.author | Gotuzzo Herencia, José Eduardo | |
dc.contributor.author | White Jr., A.C. | |
dc.date.accessioned | 2022-01-18T19:26:51Z | |
dc.date.available | 2022-01-18T19:26:51Z | |
dc.date.issued | 2011 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/10949 | |
dc.description.abstract | Regulatory T cells (Tregs) blunt uncontrolled immune responses. In advanced human immunodeficiency virus (HIV) infection, the total number of Tregs is decreased, but the proportion of T cells with a regulatory phenotype is highly variable. We studied CD4+CD25+FoxP3+ T cells from patients successfully treated with combination antiretroviral therapy (ART). The proportion of CD4+CD25+FoxP3+ cells transiently increased and then decreased from a median of 13% at baseline to 5.1% at 48 weeks, similar to values in normal subjects. These data suggest that with effective therapy, the regulatory cell numbers normalize, and that the inflammatory signals driving their production may also abate. | en_US |
dc.language.iso | eng | |
dc.publisher | Oxford University Press | |
dc.relation.ispartofseries | Journal of Infectious Diseases | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Humans | en_US |
dc.subject | Drug Efficacy | en_US |
dc.subject | HIV Infections | en_US |
dc.subject | Human Immunodeficiency Virus Infection | en_US |
dc.subject | Clinical |Peripheral Blood Mononuclear Cell | en_US |
dc.subject | Virus Load | en_US |
dc.subject | CD4 Lymphocyte Count | en_US |
dc.subject | Highly Active Antiretroviral Therapy | en_US |
dc.subject | Treatment Response | en_US |
dc.subject | Antiretroviral Therapy Highly Active | en_US |
dc.subject | Anti-HIV Agents | en_US |
dc.subject | Regulatory T Lymphocyte | en_US |
dc.subject | Transcription Factor FOXP3 | en_US |
dc.subject | RNA Directed DNA Polymerase Inhibitor | en_US |
dc.subject | CD4+ CD25+ T Lymphocyte | en_US |
dc.subject | Forkhead Transcription Factors | en_US |
dc.subject | Interleukin-2 Receptor Alpha Subunit | en_US |
dc.subject | T-Lymphocytes Regulatory | en_US |
dc.subject | Lymphocyte Count | en_US |
dc.subject | Antigens CD4 | en_US |
dc.subject | Nonnucleoside Reverse Transcriptase Inhibitor | en_US |
dc.title | Normalization of FoxP3+ regulatory T cells in response to effective antiretroviral therapy | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1093/infdis/jiq073 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1537-6613 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |